Artificial intelligence–assisted smart hydrogel bioinks in 3D bioprinting: design, optimization, and construct validation for functional tissue engineering
Frontiers in Bioengineering and Biotechnology · 10.08.2026 · 14
DOI: 10.3389/fbioe.2026.1898243 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 10.08.2026. Verfasst von Siyuan Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of IT & Data Management, West China Hospital, Sichuan University, Chengdu, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hydrogel-based bioinks are central to three-dimensional (3D) bioprinting because they provide hydrated, cell-supportive microenvironments with tunable rheological, mechanical, and biological properties. Smart hydrogel bioinks further introduce stimuli-responsive and dynamic behaviors, but their development remains constrained by empirical trial-and-error workflows and weak integration among formulation design, printability, process monitoring, and post-print biological performance. This review develops an AI-assisted workflow framework for smart hydrogel bioink development rather than treating smart materials, algorithms, and autonomous laboratories as separate mature topics. We examine how artificial intelligence (AI) can support feature representation, property prediction, printability assessment, process optimization, monitoring, construct characterization, and iterative refinement. Particular emphasis is placed on distinguishing direct evidence in smart hydrogel bioinks from broader bioprinting evidence, adjacent-field methodological inspiration, and prospective autonomous concepts. We also clarify the boundaries among supervised prediction, Bayesian optimization, active learning, computer vision, feedback control, and AI-agent-assisted workflow coordination. Finally, we discuss validation, benchmarking, grouped data splitting, uncertainty estimation, out-of-distribution detection, and the need to connect early material and process descriptors with long-term biological function. Overall, AI-assisted methods can make hydrogel bioprinting more predictive and quality-oriented, but real-time closed-loop control and fully autonomous bioink laboratories remain prospective goals that require standardized datasets, validated biological endpoints, uncertainty-aware models, external validation, and human oversight.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of IT & Data Management, West China Hospital, Sichuan University, Chengdu, China.
- Information Center, Beijing Anzhen Nanchong Hospital, Capital Medical University & Nanchong Central Hospital, Nanchong, China.
- Department of Neurology, The Second Clinical Medical College, Ningxia Medical University, Yinchuan, China.
- Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zitieren
APA
Zhang, S., Liang, D., Lei, Y., Luo, Y., & Shi, R. (2026). Artificial intelligence–assisted smart hydrogel bioinks in 3D bioprinting: design, optimization, and construct validation for functional tissue engineering. Frontiers in Bioengineering and Biotechnology, 14. https://doi.org/10.3389/fbioe.2026.1898243
Vancouver
Zhang S, Liang D, Lei Y, Luo Y, Shi R. Artificial intelligence–assisted smart hydrogel bioinks in 3D bioprinting: design, optimization, and construct validation for functional tissue engineering. Frontiers in Bioengineering and Biotechnology. 2026;14. doi:10.3389/fbioe.2026.1898243
BibTeX
@article{Zhang2026,
author = {Zhang, Siyuan and Liang, Dingwen and Lei, Yingying and Luo, Yuxi and Shi, Rui},
title = {Artificial intelligence–assisted smart hydrogel bioinks in 3D bioprinting: design, optimization, and construct validation for functional tissue engineering},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2026},
volume = {14},
doi = {10.3389/fbioe.2026.1898243}
}
EUVIMED